Elucidating the prognostic utility of ultra-early HMGB1 for the development of cognitive sequelae after ischemic stroke is an important step toward identifying at-risk patients for targeted monitoring and preventative therapies, as well as unraveling the complex mechanisms of post-stroke neuroinflammation and secondary neurodegeneration. The gene discussed is HMGB1; the disease is stroke disorder.